News and Community

Agendia, Ai-driven, Brca1, Brca2, Digital Health, Digital Pathology, Esmo 2026, Flex Study, Genomic Risk, Genomic Testing, Healthcare Technology, Ki67, Mammaprint, Oncology Research, Precision Medicine, Precision Oncology, Real-world Evidence

October 7, 2026

Agendia to Present AI-Driven Digital Pathology Research at ESMO 2026

Alpha Therapy, Cancer Therapies, Cancer Treatment, Healthcare Technology, Lead-212, Nuclear Medicine, Oncology, Orano Med, Precision Oncology, Radioligand Therapies, Radioligand Therapy, Targeted Alpha Therapies, Targeted Alpha Therapy

October 5, 2026

Orano Med Opens ATLab Valenciennes, Europe’s First Industrial Facility for Lead-212 Targeted Alpha Therapies

Acıbadem, Cancer Treatment, Healthcare Technology, Medical Technology, Mevion S250-fit, Precision Oncology, Proton Therapy, Radiation Oncology

September 29, 2026

Acıbadem Selects MEVION S250-FIT for Türkiye’s First Private Proton Therapy Program

Blood-based Screening, Cancer Screening, Colorectal Cancer Screening, Colorectal Cancer Test, Crc Screening, Evernorth, Evicore, Guardant Health, Healthcare Technology, Precision Oncology, Shield Blood Test

September 15, 2026

Guardant Health’s Shield Blood Test Gains EviCore by Evernorth Coverage for Colorectal Cancer Screening

Aacr 2026, Ai In Healthcare, Ai Platform For Drug Development, Biomedical Data, Bostongene, Cancer Research, Drug Discovery, Precision Oncology

April 10, 2026

BostonGene to Showcase AI Platform for Drug Development with 13 Abstracts at AACR Annual Meeting 2026

Cancer Therapies, Companion Diagnostics, Guardant Health, Guardant Infinity Smart Platform, Liquid Biopsy, Merck, Precision Oncology

January 20, 2026

Guardant Health & Merck Develop Companion Diagnostics & Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform